A method was developed for recording isometric tension from isolated small arteries (mean internal diameter, 169 jim) and veins (mean internal diameter, 273 ,um) of the term fetal lung and was then applied to the study of the mechanisms controlling perinatal pulmonary hemodynamics. The specific purpose was to determine whether the activity of the prostaglandin synthetic system in vessels is conditioned by the oxygen tension and the mode of action of endothelin-1. Both preparations appeared structurally intact and, after normalizing their lumen diameter to either the transmural pressure in vivo (artery) or the contractile capacity of the vessel in vitro (vein), generated force to the activating solution (5 mM Ca2' in K' Krebs' solution) in excess of the expected performance under physiological conditions. Treatment with indomethacin (2.8 ,M) had no effect on arteries preequilibrated at low Po2 (21± 1 mm Hg); however, the same treatment contracted (-45% of the response to activating solution) arteries at either an intermediate (40±0.8 mm Hg) or high (70±0.9 mm Hg) Po2. Endothelin-1 contracted both arteries and veins in a concentration-dependent manner, the threshold being lower with veins (1-10 versus 10-100 pM). Endothelin-1 constriction was also seen in arteries whose tone had been raised with a thromboxane A2 analogue, whereas in thromboxane-treated veins constriction was preceded by a modest relaxation over the range of 1-1,000 pM. The findings with indomethacin lead us to infer that small pulmonary arteries are endowed with a prostaglandin-relaxing mechanism that becomes functional on raising the P02 from fetal to neonatal levels. Endothelin-1 is a constrictor regardless of the level of intrinsic tone, suggesting a possible role of the peptide in maintaining elevated pulmonary vascular tone in the fetus. (Circulation Research 1992;71:320-330) KEY WoRDs * fetus * pulmonary vascular resistance * endothelin * oxygen * prostaglandins T he pulmonary circulation undergoes major changes during the transition from the fetal to the neonatal state, resulting in a fall in vascular resistance.1 Through the years, the mechanisms responsible for the elevated resistance in the fetus and the dilatation of blood vessels at birth have been intensively investigated, and several vasoactive agents have been implicated in both processes.2 Among them, the dilator prostaglandin 12 (PGI2) has been viewed as a mediator for the postnatal change, whereas endothelin-1 (ET-1) has been assigned both a prenatal and postnatal role, since its action reportedly combines dilator and constrictor components.3-6 However, the actual importance of PGI2 has been questioned recently after evidence was obtained indicating that prostaglandin synthesis in the fetal lung is activated by ventilation per se rather than by the rise in blood oxygen tension. The purpose of our investigation was to ascertain whether resistance blood vessels in the fetal lung are under the control of an intramural prostaglandin with relaxing properties and, if so, whether the expression of this mechanism is conditioned by the level of oxygenation. An additional objective was to determine whether ET-1 lends itself to a role in maintaining the pulmonary vascular tone elevated in utero. Before approaching these questions, we developed an isolated preparation of small arteries and veins from the fetal lung as a general tool for the study of local factors controlling by guest
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Treatment with indomethacin (2.8 ,M) had no effect on arteries preequilibrated at low Po2 (21± 1 mm Hg); however, the same treatment contracted (-45% of the response to activating solution) arteries at either an intermediate (40±0.8 mm Hg) or high (70±0.9 mm Hg) Po2. Endothelin-1 contracted both arteries and veins in a concentration-dependent manner, the threshold being lower with veins (1-10 versus 10-100 pM). Endothelin-1 constriction was also seen in arteries whose tone had been raised with a thromboxane A2 analogue, whereas in thromboxane-treated veins constriction was preceded by a modest relaxation over the range of 1-1,000 pM. The findings with indomethacin lead us to infer that small pulmonary arteries are endowed with a prostaglandin-relaxing mechanism that becomes functional on raising the P02 from fetal to neonatal levels. Endothelin-1 is a constrictor regardless of the level of intrinsic tone, suggesting a possible role of the peptide in maintaining elevated pulmonary vascular tone in the fetus. (Circulation Research 1992;71:320-330) KEY WoRDs * fetus * pulmonary vascular resistance * endothelin * oxygen * prostaglandins T he pulmonary circulation undergoes major changes during the transition from the fetal to the neonatal state, resulting in a fall in vascular resistance.1 Through the years, the mechanisms responsible for the elevated resistance in the fetus and the dilatation of blood vessels at birth have been intensively investigated, and several vasoactive agents have been implicated in both processes.2 Among them, the dilator prostaglandin 12 (PGI2) has been viewed as a mediator for the postnatal change, whereas endothelin-1 (ET-1) has been assigned both a prenatal and postnatal role, since its action reportedly combines dilator and constrictor components.3-6 However, the actual importance of PGI2 has been questioned recently after evidence was obtained indicating that prostaglandin synthesis in the fetal lung is activated by ventilation per se rather than by the rise in blood oxygen tension.78 In addition, certain data would limit the action of PGI2 to the period immediately following birth or would even imply an accessory function for the compound.2,9'10 Likewise, uncertainties remain about the nature of the involvement of ET-1 in transitional adjustments, since there is incomplete knowledge of the factors conditioning the direction of responses,4'6"11 and accordingly, experimental findings cannot be translated into a precise functional scheme. A difficulty in evaluating the work to date is that results have been obtained in either the isolated lung (in vitro or in situ) or the intact animal. Hence, no information is available on the responsiveness of pulmonary resistance vessels in the absence of any confounding influence from vasoactive agents being formed in the lung parenchyma and the blood cells.
The purpose of our investigation was to ascertain whether resistance blood vessels in the fetal lung are under the control of an intramural prostaglandin with relaxing properties and, if so, whether the expression of this mechanism is conditioned by the level of oxygenation. An additional objective was to determine whether ET-1 lends itself to a role in maintaining the pulmonary vascular tone elevated in utero. Before approaching these questions, we developed an isolated preparation of small arteries and veins from the fetal lung as a general tool for the study of local factors controlling pulmonary vascular resistance in the fetus and the adjustments of the circulation at birth. Figure 1 provides a schematic diagram with the individual components and the isolated vessel. The whole assembly rested on floating tires to avoid any mechanical interference from the environment. The bath was supplied from different reservoirs, and a system of three-way valves allowed the perfusion fluid to be changed rapidly. Both reservoir and organ bath were continuously bubbled with the required gas mixture, and the same mixture was flushed through the hood covering the bath (Figure 1 , H). When first set up, the preparation was immersed in Krebs' medium equilibrated with the low-oxygen mixture. Perfusion rate was 5 ml/min. Dimensions of the vessels were measured to within 1-2 ,um according to Mulvany and Halpern, 13 and each measurement was the average of three to four values. The overall compliance of the recording system, as inferred from visual assessment of the distance between the two wires before and after treating the preparation with activating solution, was below the limit of detection (<1 ,m/mN).
Materials and Methods

Recording of Mechanical Activity
The general procedure for normalizing the internal circumference of vessels and establishing the conditions for recording mechanical tension followed published protocols.13'4 It included several steps, which, unless specified otherwise, were all carried out with the lowoxygen Krebs' medium.
Equilibration. Immediately after being mounted in the bath, preparations were measured without tension being applied. Afterwards, they were stretched in increments of 10-15 ,um/min until tension output was 0.12-0.15 and 0.2 mN/mm for arteries and veins, respectively. For the arteries, this wall tension was equivalent to approximately 30% of the expected transmural pressure in vivo; the value for the veins was arbitrary (see below).
Preparations were kept under such a load for 60-90 minutes, and once the equilibration was completed, they were exposed twice to the sequence of relaxing solution and activating solution (both at low oxygen). The vessels were included in the study if contractile responses to the activating solution did not differ by more than 20%. Once this condition had been met, the applied load was removed, and then a barely detectable tension (.0.02 mN/mm) was applied to measure the vessel again. This resting dimension (Table 1 ) was used as a reference for selecting the appropriate operating load and attendant internal circumference (see below).
Normalization of internal circumference. Theoretically, internal circumference of any vessel in vitro is optimal when wall tension is equivalent to the transmural pressure in vivo. In accordance with this premise, LaPlace's equation was used for extrapolating an appropriate value of tension for the small pulmonary arteries. In following this approach, it was assumed that wall thickness is negligible, that the equation is applicable despite the deformation being imposed on the vessel wall by the wires, and that intraluminal pressure is 30 mm Hg. The latter value was calculated from reported measurements of pulmonary arterial and left atrial pressures in the fetal lamb (50 and 5 mm Hg, respec- 15 Accordingly, the internal circumference corresponding to the transmural pressure in vivo was expressed as C30, and this value was taken as a reference in determining the circumference-tension relation. For normalization, arteries were stretched in 0.1-C30 increments over a range between 0.7 and 1.1 C30 using a random order, and at each step relaxing and activating solutions were passed in sequence through the bath to measure the active wall tension. (Active wall tension was assessed from the response to activating solution; however, relaxing solution was used first to prime the vessel to the depolarizing action of potassium.) Resting tension was measured in Krebs' medium rather than relaxing solution, because, despite the absence of calcium, the latter solution did not completely abolish tone (see "Results"). Based on the shape of the resulting curves (see "Results"), the operating circumference was set at a value lower (i.e., 0.9 C30) than the theoretical optimum to maximize the active component in the tension output of the preparation. Control experiments confirmed that the latter value was also valid with vessels preequilibrated at high Po2.
Unlike the arteries, LaPlace's equation could not be used with the veins. Based on the transmural pressure in vivo, the calculated wall tension was exceedingly small and clearly was not matched to the contractile potential of the vessel. To overcome this methodological problem, the internal circumference-tension relation was measured over the range between 1 and 1.6 CO, where CO was the internal circumference of the vein under minimal stretch (see above). In the actual experiment, however, 1.5 CO was taken arbitrarily as the operating circumference, since it provided maximal stretch without any significant reduction in the length of the vessel (see "Results").
Criteria for acceptance ofpreparations. With arteries, experiments were accepted only if the active tension developed in response to the activating solution at an optimal internal circumference (i.e., C30) exceeded the expected value derived from LaPlace's transformation of the transmural pressure in vivo (i.e., 30 
Light and Electron Microscopy
Morphological examination was carried out in arteries and veins that had been prepared in the usual manner and had also been threaded onto tungsten wires. Both vessels had not been used for pharmacological tests; however, they had been kept longer (i.e., 4-5 hours) in the dissection chamber.
For routine histology, vessels were fixed in 1% glutaraldehyde/4% formaldehyde in 0.1 M phosphate buffer and were embedded in paraffin. Transversal sections were examined after staining with Movat pentachrome stain.
Scanning and transmission electron microscopy was used to assess the integrity of the endothelium. For this purpose, vessels were cut open along the main axis, gently stretched, and pinned to a wax board before fixation as described above. Whereas the entire luminal surface of the vessel was examined by scanning electron microscopy, serial sections (maximum, 10 per vessel) were used for transmission electron microscopy. For scanning electron microscopy, specimens were dehydrated in acetone, critical-point-dried using liquid C02, sputter-coated with gold/palladium, and examined in a JEOL instrument (model 840, JEOL U.S.A. Inc., Peabody, Mass. 
Contractile Behavior of Arteries and Veins
After equilibration and the required normalization of the internal circumference (see below), preparations of both arteries and veins displayed a steady baseline, which, in the absence of any intervening pharmacolog- ical treatment, was maintained for the whole period of observation (maximum, 9 hours). Their behavior was the same, regardless of the actual load applied and the oxygen tension of the medium. In addition, in no instance did the vessels develop spontaneous motility under basal conditions.
Response to relaxing and activating solutions. Typically, relaxing solution produced a quick, albeit transient, contraction in the arteries ( Figure 3A, inset) . Spontaneous reversal, however, was never complete, and tone remained elevated to a variable degree despite the continued exposure to the solution (maximum, 15 minutes). Restoration of the original baseline occurred when the normal Krebs' medium was reintroduced into the bath. In contrast, activating solution elicited a larger and sustained contraction, comprising two phases (Figure 3A, inset) , and only exceptionally did the response abate before the preparation was washed. The actual pattern of the contraction, and specifically its late phase, differed among experiments. In 63% of the vessels, the contraction progressed rapidly to a first plateau from which a secondary, and far smaller, contraction developed that also reached rapidly a stable level. Figure 3A (inset) exemplifies this particular pattern. In the remaining vessels, however, the late contraction was slower, although a peak was eventually attained within approximately 12 minutes, or there was a modest relaxation between the first and second peak. Regardless of its appearance, the response subsided in full upon exchanging the activating with the Krebs' solution. Veins behaved as did the arteries in reacting to either the relaxing or activating solution, and responses had the expected time course and overall profile.
Internal circumference-wall tension relation. When subjected to an increasing load, arteries displayed progressively higher tension at rest and larger responses to the activating solution ( Figure 3A) . However, the change in resting tension was relatively greater so that curves denoting the two variables met when internal circumference slightly exceeded the theoretical optimum. As shown in Figure 4 , the relation between internal circumference and wall tension took a different form in the case of the veins. Resting tension increased with the internal circumference of the vessel, but the change was modest compared with that observed in the arteries. More important, the two curves, expressing resting and active tensions, developed almost in parallel and did not join, at least over the range of dimensions being considered. At the highest value of internal circumference, however, development of tension was associated with a significant shortening (5-10%) of the vessel.
Choice of internal circumference. Analysis of the curves relating wall tension with internal circumference ( Figures 3A and 4) provided the means for determining the most appropriate basal load for both arteries and veins. In the case of the arteries, the load of choice stretched the vessel wall to 0.9 of the expected measure in vivo (i.e., 0.9 C/C30). This arteries at 0.9 C/C30 was consistent through repeated challenges with the activating solution ( Figure 3B ). In fact, the greatest difference between individual responses in the sequence of Figure 3B a peak and could not be used as a reference by itself. In that case, the choice of internal circumference also took into account the length of the vessel, and the selected value (1.5 C/CO) ensured maximal tension output with minimal shortening (<5%). Active tension from normalized veins was comparable in magnitude to that of arteries ( Figures 3A and 4) , and likewise, its development was consistent through repeated cycles of stimulation.
Effects of Indomethacin
When added to the perfusion medium, indomethacin (2.8 ,M) had no constrictor effect on arteries preequilibrated in the low-oxygen medium (Table 2 ). In contrast, a marked contraction occurred when Po2 was raised to intermediate or high levels (Table 2) , although oxygen by itself was ineffective. The response to indomethacin began after a 6-25-minute delay, progressed gradually to a plateau (peak in 68-123 minutes), and was sustained for as long as the drug was present in the bathing fluid (maximum, 3 hours). Treated arteries never exhibited spontaneous activity, regardless of the level of tone and the length of exposure to the drug.
Effects of Endothelin-1
Naive preparations. ET-1 contracted arteries and veins in a concentration-dependent manner ( Figure 5 ). Threshold concentration was lower with veins (1-10 versus 10-100 pM), and the same vessels also developed a stronger contraction at the peak concentration (i.e., 10 nM). With both preparations, responses were immediate in onset, progressed rapidly to a maximum (peak in 3-10 minutes at 10 nM), and in most instances (>90%) were fully reversible on removal of the compound ( Figures SA and 5B, inset) . The rate of reversal, how- ever, was faster with the veins than the arteries (mean value, 19 versus 24 minutes at 1-10 nM). While contracting either pulmonary vessel, in 40% of the experiments ET-1 elicited phasic discharges of variable amplitude and synchronization, which persisted at times beyond the tonic phase of the response. The general pattern of contraction in arteries did not change on transfer from a low to a high Po2; however, ET-1 was less effective at high Po2 (Figure 6 ).
Indomethacin-treated preparations. Pretreatment of arteries with indomethacin (2.8 ,uM) did not alter the response to ET-1 insofar as sign, time course, and degree of reversal are concerned. Whereas the general pattern was preserved, however, preparations became more sensitive to the peptide. As shown in Figure 7 , EC50 values dropped especially at the high Po2, and significantly, the difference noted in naive preparations between low and high Po2 was abolished. Threshold concentration was also consistently lower (i.e., 1 pM) in treated arteries, whereas maximal response showed no obvious change.
Thromboxane-contracted preparations. The TXA2 analogue was used to raise the tone of both vessels and unmask any dilator component in ET-1 action. By itself, the analogue elicited an immediate contraction, which progressed rapidly (6-13 minutes) to a sustained plateau. The maximally effective concentration was usually higher for arteries (0.1-1 ,uM) than for veins (-0.01 ,uM). With either preparation, the response exceeded by 20-60% that to the activating solution and often had phasic discharges superimposed (63% and 33% of the experiments for arteries and veins, respectively). Application of ET-1 to the thromboxane-treated artery produced a further contraction, during which threshold and peak concentrations were comparable to those of the untreated artery ( Figure 8A ). By contrast, in the vein, a modest relaxation was seen up to the 1-nM concentration, and the succeeding contraction was smaller and did not reach a maximum over the concentration range examined ( Figure 8B ). The ET-1 relaxation had a quick onset and persisted through a 4-minute application. Discussion The present investigation proves the feasibility of setting up an in vitro preparation of fetal pulmonary arteries and veins to examine local factors responsible for hemodynamic control. Both vessels appeared to be structurally intact and had a viable contractile apparatus after isolation. Their function was also appropriate insofar as responsiveness to vasoactive agents is concerned. Specifically, indomethacin constricted the arteries, and its action required a critical level of oxygen to occur. ET-1 was a potent constrictor of both arteries and veins; however, veins also exhibited a modest dilator component in their response. Based on these data, our discussion will concern three issues, namely, the usefulness of this novel preparation for studying mechanisms controlling perinatal pulmonary hemodynamics, the implications of findings with indomethacin for a role of PGI2 in the relaxation of pulmonary vessels at birth, and the feasibility of ET-l's functioning as a natural pulmonary constrictor in maintaining the elevated tone that is typical of the fetal state. A general difficulty in studying regional hemodynamics and its regulation is that experiments in vivo, or on any intact organ in vitro, cannot separate vascular from parenchymal agents, whereas experiments with isolated vascular preparations are usually restricted to conductance vessels, and the attendant data may not be relevant to the control mechanism. To overcome this methodological problem, isolated preparations of resistance vessels have been developed and applied to the study of diverse vascular regions.17 Our work proves that this approach is also feasible with the perinatal pulmonary circulation, notwithstanding the extensive branching of the terminal vasculature and the intrinsic fragility of tissues. In brief, it is safe to conclude that this novel preparation, using arteries and veins, lends itself well to the study of the fetal pulmonary circulation and its transitional adjustments. Contrary to recent reports in which acceleration of prostaglandin synthesis occurring in lungs at the time of birth has been linked to the mechanical effect of ventilation,7'8 we have found that synthesis within the wall of the small arteries is crucially dependent on oxygen for its activation. Indomethacin per se did not alter the tone of vessels preequilibrated at low Po2, whereas it became a constrictor at high Po2. In addition, the inhibitor was effective in enhancing the response to ET-1, which implies that, once triggered by oxygen, the action of intramural prostaglandins is exerted on vascular smooth muscle both directly and through the modulation of vasoconstrictor stimuli. In this connection, it early in gestation -indeed, it is more active in the fetus than in the adult -and is found in several cell constituents, including endothelium.33'34 Furthermore, formation of the peptide is accelerated by hypoxia, at least in the adult.35 These data, coupled with our finding of the potent constrictor effect of ET-1 on pulmonary resistance vessels, are in accord with the idea of the peptide's contributing directly to the elevated pulmonary vascular tone of the fetus. Though appealing, however, this concept is in apparent contrast with recent studies in vivo and the perfused organ in vitro, in which ET-1 proved to be primarily, and under certain conditions exclusively, a dilator of the perinatal pulmonary circulation. [3] [4] [5] [6] In one of the in vivo studies,4 ET-1 action was conditioned by the tone of the vasculature, with dilatation occurring prenatally and constriction becoming prominent postnatally. Theoretically, several facts could explain this apparent inconsistency: 1) Isolated vessels lack a viable endothelium and, consequently, are unable to produce dilator agents, such as nitric oxide and PGI2, in response to ET-1.36 2) Contractile tone in vitro is inadequate for the expression of receptors mediating vasodilatation. 4 3) The target for ET-1 vasodilatation is confined to a segment of the pulmonary vasculature that is not accessible to our in vitro technique. 4) Bloodborne (or perfusate-borne) ET-1 alters pulmonary hemodynamics both directly and through the release of vasoactive agent(s) from the parenchyma. In actual fact, however, we have demonstrated that isolated pulmonary vessels are functionally intact and lack a significant relaxant response to ET-1 even when their intrinsic tone is maximally elevated. On the other hand, vessels of the order of magnitude of our preparation contribute significantly to pulmonary vascular resistance in vivo and, by inference, should also function as a target for any vasodilator agent. By exclusion, the idea of ET-l's exerting a dilator effect in the intact organ by promoting the formation of some vasoactive agent from the parenchyma seems most plausible. Under appropriate conditions, any such agent could override the direct constrictor effect of ET-1 on the vasculature. If this is indeed the case, our findings in vitro should be a better reflection of the situation in vivo, because ET-1 is viewed as a local mediator being formed and acting within the vessel wall.
In conclusion, we regard this isolated preparation of pulmonary resistance vessels as a valuable tool for studying the perinatal pulmonary circulation. Using this preparation, we have demonstrated that the pulmonary vasculature has a prostaglandin-relaxing mechanism that is best expressed under conditions of oxygenation mimicking the neonatal condition. ET-1 is a potent constrictor of the isolated vessels, and its action is compatible with a role in keeping the pulmonary vascular tone elevated in the fetus.
